B
Brian Wigdahl
Researcher at Drexel University
Publications - 229
Citations - 6653
Brian Wigdahl is an academic researcher from Drexel University. The author has contributed to research in topics: Virus & Long terminal repeat. The author has an hindex of 41, co-authored 215 publications receiving 5987 citations. Previous affiliations of Brian Wigdahl include Thomas Jefferson University & Pennsylvania State University.
Papers
More filters
Journal ArticleDOI
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy.
Andrew Atkins,Cheng-Han Chung,Alexander G. Allen,Will Dampier,Theodore E Gurrola,Ilker Kudret Sariyer,Michael R. Nonnemacher,Brian Wigdahl,Brian Wigdahl +8 more
TL;DR: In this paper, a review examines the strengths, limitations, and origins of the different classes of off-target cleavage detection systems including anchored primer enrichment (GUIDE-seq), in situ detection (BLISS), in vitro selection libraries (CIRCLE-seq) and in vitro genomic DNA digestion (Digenome-seq and SITE-Seq).
Journal ArticleDOI
Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer.
TL;DR: Electrophoretic mobility shift analyses utilizing double-stranded oligonucleotides homologous to each of the 21 bp repeats and nuclear extracts derived from selected cell lines of lymphocytic, neuronal, and glial origin suggest that the differential binding of cellular factors may play a role in basal as well as Tax-mediated LTR-directed transcription within cell populations of either immune or nervous system origin.
Journal ArticleDOI
A nipple shield delivery system for oral drug delivery to breastfeeding infants: Microbicide delivery to inactivate HIV
Stephen E. Gerrard,Mary Lynn Baniecki,David C. Sokal,Mary Kate Morris,Sandra Urdaneta-Hartmann,Fred C. Krebs,Brian Wigdahl,Barbara Abrams,Carl V. Hanson,Nigel K.H. Slater,Alexander D. Edwards +10 more
TL;DR: Efficient drug delivery to breastfeeding infants is achievable using the NSDS, and greater than 99% reduction of cell-associated HIV infectivity was achieved in the first 10 ml of milk.
Journal ArticleDOI
Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.
TL;DR: The substitution of BVDU with 9-[(2-hydoxyethoxy)methyl]guanine (acyclovir; ACV) during a combined treatment with IFN-alpha inhibited HSV-1 replication and established in vitro virus latency that could be maintained for a longer period after inhibitor removal and a continued incubation at 37 degrees C.
Journal ArticleDOI
Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.
Anthony R. Mele,Jamie Marino,Kenneth S. Chen,Vanessa Pirrone,Chris Janetopoulos,Brian Wigdahl,Brian Wigdahl,Zachary Klase,Michael R. Nonnemacher,Michael R. Nonnemacher +9 more
TL;DR: The human immunodeficiency virus type 1 (HIV‐1) transactivator of transcription (Tat) protein functions both intracellularly and extracellularly, and its effects have been examined in HIV‐1‐associated neurocognitive disorders (HAND).